Somewhat predictably, EFSA found "no new potential hazards, and thus, no new risks to humans, animals, or the environment are anticipated" from the use of these techniques in animals, beyond those ...

As previously announced, Teknova and Pluristyx are collaborating to produce and commercialize the PluriFreeze product line, with Teknova becoming the exclusive manufacturer and distributor in the ...

Marco Marra spent five years earning his PhD by studying DNA fragments of roundworms, fascinated by the notion that ...

A new study published in the journal CABI Reviews highlights the critical role that integrated pest management (IPM) plays in ...

Scientists are pioneering a revolutionary approach to combat climate change: genetically engineering cow gut microbes to ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That’s ...

With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses the multifunctionality of the natural ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

PPH researchers apply cutting-edge AI and computational models to massive datasets to develop a deep understanding of the ...

AstraZeneca’s EsoBiotec acquisition is the latest in a series of deals struck by the pharma giant to secure a place in the next wave of cell therapies for cancer and immune-mediated diseases.

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive ...